[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Agewall et al., 1995 - Google Patents

Microalbuminuria, insulin sensitivity and haemostatic factors in non‐diabetic treated hypertensive men

Agewall et al., 1995

Document ID
14072457792859186000
Author
Agewall S
Fagerberg B
Attvall S
Ljungman S
Urbanavicius V
Tengborn L
Wikstrand J
Risk Factor Intervention Study Group
Publication year
Publication venue
Journal of internal medicine

External Links

Snippet

Objective. To examine whether microalbuminuria in non‐diabetic, treated hypertensive men is associated with insulin resistance and measures of endothelial function, thrombogenesis and fibrinolysis. Design. Cross‐sectional study. Setting. Outpatient clinic in city hospital …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)

Similar Documents

Publication Publication Date Title
Agewall et al. Microalbuminuria, insulin sensitivity and haemostatic factors in non‐diabetic treated hypertensive men
Kalantar-Zadeh et al. Survival advantages of obesity in dialysis patients
Jensen et al. Features of endothelial dysfunction in early diabetic nephropathy
Jilma et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus
Skarfors et al. Do antihypertensive drugs precipitate diabetes in predisposed men?
Zimmermann et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
Chen et al. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients?
Jensen et al. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals
Steiner et al. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control
Cortellaro et al. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.
Forsblom et al. Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4
Skarfors et al. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men
Mathiesen et al. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Martinelli et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families
Eliasson et al. Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen: a population study
Mäkelä et al. Renal function and blood pressure five years after Puumala virus-induced nephropathy
Lindahl et al. Insulin resistance syndrome and fibrinolytic activity: the northern Sweden MONICA study
Smith et al. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease
Ruiz et al. Association of elevated lipoprotein (a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein (a) phenotypes
Leander et al. Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction
Rubio-Guerra et al. Correlation between circulating adhesion molecule levels and albuminuria in type-2 diabetic hypertensive patients
Tomura et al. Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population
Zakai et al. Total tissue factor pathway inhibitor and venous thrombosis
Lee et al. Prothrombotic and antithrombotic factors are elevated in patients with type 1 diabetes complicated by microalbuminuria
Agewall Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk